Previous studies indicate that cancer cells appear to display overexpression of this metabolic hypoxia-related protein in most tumor cases, and a high HIF-1α level is related to an enhanced grade of tumor aggressiveness, higher incidences of metastasis, and poor prognosis [26, 29–31]. The gene discussed is HIF1A; the disease is cancer.